Table 1.
Clinical characteristics.
| Characteristics | Control group | NAs group | NAs + FZHY group |
|---|---|---|---|
| n | 20 | 50 | 50 |
| Sex (male/female) | 12/8 | 28/22 | 30/20 |
| Age (year) | 60.30 ± 10.04 | 55.24 ± 10.13 | 56.69 ± 10.53 |
| Partial response | — | 7 | 2 |
| Complete response | — | 43 | 48 |
Clinical characteristics.
| Characteristics | Control group | NAs group | NAs + FZHY group |
|---|---|---|---|
| n | 20 | 50 | 50 |
| Sex (male/female) | 12/8 | 28/22 | 30/20 |
| Age (year) | 60.30 ± 10.04 | 55.24 ± 10.13 | 56.69 ± 10.53 |
| Partial response | — | 7 | 2 |
| Complete response | — | 43 | 48 |